O’reilly Automotive (ORLY) Holding Has Boosted by Green Valley Investors Llc; Dafna Capital Management Continues to Hold Stake in Aerie Pharmaceuticals (AERI)

February 25, 2018 - By Richard Conner

Green Valley Investors Llc increased its stake in O’reilly Automotive Inc (ORLY) by 16.33% based on its latest 2017Q3 regulatory filing with the SEC. Green Valley Investors Llc bought 26,576 shares as the company’s stock declined 6.25% while stock markets rallied. The institutional investor held 189,321 shares of the consumer services company at the end of 2017Q3, valued at $40.77 million, up from 162,745 at the end of the previous reported quarter. Green Valley Investors Llc who had been investing in O’reilly Automotive Inc for a number of months, seems to be bullish on the $21.42 billion market cap company. The stock increased 2.74% or $6.77 during the last trading session, reaching $254.13. About 608,274 shares traded. O'Reilly Automotive, Inc. (NASDAQ:ORLY) has declined 1.60% since February 25, 2017 and is downtrending. It has underperformed by 18.30% the S&P500.

Nathan Fischel increased its stake in Aerie Pharmaceuticals Inc (AERI) by 9.37% based on its latest 2017Q3 regulatory filing with the SEC. Dafna Capital Management Llc bought 10,000 shares as the company’s stock declined 8.47% while stock markets rallied. The hedge fund run by Nathan Fischel held 116,770 shares of the health care company at the end of 2017Q3, valued at $5.68 million, up from 106,770 at the end of the previous reported quarter. Dafna Capital Management Llc who had been investing in Aerie Pharmaceuticals Inc for a number of months, seems to be bullish on the $2.11 billion market cap company. The stock increased 2.47% or $1.3 during the last trading session, reaching $53.85. About 206,593 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 180.20% since February 25, 2017 and is uptrending. It has outperformed by 163.50% the S&P500.

Investors sentiment increased to 1.73 in Q3 2017. Its up 0.56, from 1.17 in 2017Q2. It is positive, as 14 investors sold AERI shares while 41 reduced holdings. 26 funds opened positions while 69 raised stakes. 34.42 million shares or 8.89% more from 31.61 million shares in 2017Q2 were reported. Ubs Asset Mngmt Americas accumulated 40,683 shares. Point72 Asset Ltd Partnership has 0.01% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 51,900 shares. Prelude Cap Management Limited Com holds 0.08% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 17,661 shares. Cranbrook Wealth Mgmt Limited Liability stated it has 0.01% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Dekabank Deutsche Girozentrale holds 0.01% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 15,900 shares. Tiaa Cref Invest Mgmt Lc reported 100,397 shares or 0% of all its holdings. Leisure Cap Mgmt reported 0.72% stake. Mirae Asset Investments accumulated 12,100 shares. 794,614 are owned by State Street Corp. Zurcher Kantonalbank (Zurich Cantonalbank) owns 0% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 1,341 shares. 414,730 are owned by Alliancebernstein Ltd Partnership. Ahl Partners Ltd Liability Partnership stated it has 6,932 shares. Stifel, Missouri-based fund reported 84,837 shares. Point72 Asia (Hong Kong) Ltd reported 230 shares stake. Sabby Mngmt Lc owns 4,726 shares.

Dafna Capital Management Llc, which manages about $196.24 million and $161.05M US Long portfolio, decreased its stake in Immunomedics Inc (NASDAQ:IMMU) by 177,249 shares to 460,451 shares, valued at $6.44 million in 2017Q3, according to the filing. It also reduced its holding in Galapagos Nv by 7,000 shares in the quarter, leaving it with 31,609 shares, and cut its stake in Bluebird Bio Inc (NASDAQ:BLUE).

Among 15 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 47 analyst reports since August 7, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, November 4 report. The company was maintained on Wednesday, August 16 by Canaccord Genuity. The rating was initiated by Aegis Capital with “Buy” on Tuesday, November 1. Cantor Fitzgerald maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) on Wednesday, October 11 with “Buy” rating. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has “Buy” rating given on Friday, September 15 by Needham. The firm has “Buy” rating given on Thursday, September 17 by Stifel Nicolaus. On Thursday, October 6 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, November 16. The company was initiated on Friday, February 17 by TH Capital. The rating was maintained by Cantor Fitzgerald on Thursday, July 20 with “Buy”.

Among 26 analysts covering O’Reilly Automotive (NASDAQ:ORLY), 16 have Buy rating, 0 Sell and 10 Hold. Therefore 62% are positive. O’Reilly Automotive had 71 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, July 31. RBC Capital Markets maintained the shares of ORLY in report on Wednesday, July 5 with “Hold” rating. Guggenheim maintained the shares of ORLY in report on Thursday, January 18 with “Buy” rating. The rating was maintained by Citigroup with “Buy” on Friday, April 29. The company was maintained on Monday, September 11 by Jefferies. The firm has “Hold” rating by RBC Capital Markets given on Friday, September 8. The stock has “Hold” rating by RBC Capital Markets on Sunday, October 22. Robert W. Baird maintained it with “Hold” rating and $290.0 target in Thursday, February 8 report. The firm earned “Equal-Weight” rating on Thursday, July 6 by Morgan Stanley. The stock of O'Reilly Automotive, Inc. (NASDAQ:ORLY) has “Neutral” rating given on Friday, July 7 by Bank of America.

Green Valley Investors Llc, which manages about $2.05 billion US Long portfolio, decreased its stake in Tjx Cos Inc (NYSE:TJX) by 17,370 shares to 616,921 shares, valued at $45.49 million in 2017Q3, according to the filing. It also reduced its holding in Vertex Pharmaceuticals Inc (NASDAQ:VRTX) by 55,686 shares in the quarter, leaving it with 129,744 shares, and cut its stake in Walt Disney Co/The (NYSE:DIS).

Investors sentiment increased to 0.93 in Q3 2017. Its up 0.17, from 0.76 in 2017Q2. It improved, as 79 investors sold ORLY shares while 194 reduced holdings. 90 funds opened positions while 164 raised stakes. 71.25 million shares or 11.93% less from 80.90 million shares in 2017Q2 were reported. King Luther Mngmt Corporation holds 68,972 shares. Aperio Gp Limited Liability Company, California-based fund reported 44,101 shares. Mutual Of America Cap Mgmt Ltd Com holds 0.04% or 11,077 shares. New York State Teachers Retirement System stated it has 0.08% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Scotia Capital owns 2,082 shares for 0.01% of their portfolio. Pacad Inv Limited owns 7,800 shares for 0.37% of their portfolio. Thomas Story Son invested 3.96% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). 160,112 were reported by Raymond James & Associates. Marble Arch Ltd Partnership has invested 4.86% of its portfolio in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Suntrust Banks invested 0% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Logan Cap holds 2,736 shares. Bkd Wealth Llc stated it has 0.29% of its portfolio in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Alps invested 0% in O'Reilly Automotive, Inc. (NASDAQ:ORLY). Brinker invested in 0.02% or 1,742 shares. Marshall Wace Limited Liability Partnership invested in 0.03% or 3,451 shares.

Since August 25, 2017, it had 0 buys, and 12 sales for $12.81 million activity. OREILLY LAWRENCE P also sold $986,993 worth of O'Reilly Automotive, Inc. (NASDAQ:ORLY) shares. Shares for $2.50M were sold by SHAW JEFF M on Wednesday, January 3. Another trade for 5,000 shares valued at $1.35M was sold by Groves Jeffrey Lynn. $224,619 worth of O'Reilly Automotive, Inc. (NASDAQ:ORLY) was sold by JOHNSON RANDY. $1.00M worth of O'Reilly Automotive, Inc. (NASDAQ:ORLY) was sold by WOOTEN ROSALIE OREILLY. MURPHY JOHN RAYMOND had sold 400 shares worth $98,068 on Tuesday, February 13.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>